{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:30:33Z","timestamp":1770463833880,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-023-10340-3","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T07:01:46Z","timestamp":1695193306000},"page":"367-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-4820","authenticated-orcid":false,"given":"Frank L.","family":"Dini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erberto","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Riccardo","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giangiacomo","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Correale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Gabriele","family":"Tocchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Mercurio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Palazzuoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Heart Failure Study Group of the Italian Society of Cardiology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"10340_CR1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599\u20133726","journal-title":"Eur Heart J"},{"key":"10340_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10741-019-09826-w","volume":"25","author":"D Mele","year":"2020","unstructured":"Mele D, Andrade A, Bettencourt P et al (2020) From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure. Heart Fail Rev 25:217\u2013230","journal-title":"Heart Fail Rev"},{"key":"10340_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/jcm12020693","volume":"12","author":"A Palazzuoli","year":"2023","unstructured":"Palazzuoli A, Correale M, Iacoviello M, Gronda E (2023) Does the Measurement of ejection fraction still make sense in the HFpEF framework? What recent trials suggest. J Clin Med 12:693","journal-title":"J Clin Med"},{"key":"10340_CR4","doi-asserted-by":"publisher","unstructured":"Palazzuoli A, Ruocco G, Valente S et al (2022) Non-invasive assessment of acute heart failure by Stevenson classification: does echocardiographic examination recognize different phenotypes? Front Cardiovasc Med 9. https:\/\/doi.org\/10.3389\/FCVM.2022.911578","DOI":"10.3389\/FCVM.2022.911578"},{"key":"10340_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeac127","author":"FL Dini","year":"2022","unstructured":"Dini FL, Pestelli G, Pugliese NR et al (2022) Combining echo-derived haemodynamic phenotypes and myocardial strain for risk stratification of chronic heart failure with reduced ejection fraction. Eur Hear J - Cardiovasc Imaging. https:\/\/doi.org\/10.1093\/ehjci\/jeac127","journal-title":"Eur Hear J - Cardiovasc Imaging"},{"key":"10340_CR6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/ehf2.13779","volume":"9","author":"FL Dini","year":"2022","unstructured":"Dini FL, Carluccio E, Bitto R et al (2022) Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril\/valsartan. ESC Hear Fail 9:1107\u20131117. https:\/\/doi.org\/10.1002\/ehf2.13779","journal-title":"ESC Hear Fail"},{"key":"10340_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/ehf2.13183","volume":"8","author":"V Chubuchny","year":"2021","unstructured":"Chubuchny V, Pugliese NR, Taddei C et al (2021) A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance. ESC Hear Fail 8:1216\u20131229. https:\/\/doi.org\/10.1002\/ehf2.13183","journal-title":"ESC Hear Fail"},{"key":"10340_CR8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1056\/nejm197612162952505","volume":"295","author":"JS Forrester","year":"1976","unstructured":"Forrester JS, Diamond G, Chatterjee K, Swan HJC (1976) Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 295:1404\u20131413. https:\/\/doi.org\/10.1056\/nejm197612162952505","journal-title":"N Engl J Med"},{"key":"10340_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/01.CIR.96.4.1165","volume":"96","author":"AE Steimle","year":"1997","unstructured":"Steimle AE, Stevenson LW, Chelimsky-Fallick C et al (1997) Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 96:1165\u20131172. https:\/\/doi.org\/10.1161\/01.CIR.96.4.1165","journal-title":"Circulation"},{"key":"10340_CR10","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/0002-9149(90)91166-4","volume":"66","author":"LW Stevenson","year":"1990","unstructured":"Stevenson LW, Tillisch JH, Hamilton M et al (1990) Importance of hemodynamic response to therapy in predicting survival with ejection fraction \u2264 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 66:1348\u20131354. https:\/\/doi.org\/10.1016\/0002-9149(90)91166-4","journal-title":"Am J Cardiol"},{"key":"10340_CR11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.119.042660","volume":"140","author":"MH Drazner","year":"2019","unstructured":"Drazner MH, Stevenson LW (2019) Relief and prevention of congestion in heart failure enhance quality and length of life. Circulation 140:1380\u20131382","journal-title":"Circulation"},{"key":"10340_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeac254","author":"NR Pugliese","year":"2023","unstructured":"Pugliese NR, Pellicori P, Filidei F et al (2023) The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure. Eur Hear J - Cardiovasc Imaging. https:\/\/doi.org\/10.1093\/ehjci\/jeac254","journal-title":"Eur Hear J - Cardiovasc Imaging"},{"key":"10340_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","volume":"398","author":"JA Lindenfeld","year":"2021","unstructured":"Lindenfeld JA, Zile MR, Desai AS et al (2021) Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet 398:991\u20131001. https:\/\/doi.org\/10.1016\/S0140-6736(21)01754-2","journal-title":"Lancet"},{"key":"10340_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13527","author":"KH Kim","year":"2021","unstructured":"Kim KH, Jentzer JC, Wiley BM et al (2021) Diamond-Forrester classification using echocardiography haemodynamic assessment in cardiac intensive care unit patients. ESC Hear Fail. https:\/\/doi.org\/10.1002\/ehf2.13527","journal-title":"ESC Hear Fail"},{"key":"10340_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0735-1097(98)00165-X","volume":"31","author":"PL Temporelli","year":"1998","unstructured":"Temporelli PL, Corr\u00e0 U, Imparato A et al (1998) Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure. J Am Coll Cardiol 31:1591\u20131597. https:\/\/doi.org\/10.1016\/S0735-1097(98)00165-X","journal-title":"J Am Coll Cardiol"},{"key":"10340_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0002-8703(96)90316-6","volume":"132","author":"E Traversi","year":"1996","unstructured":"Traversi E, Pozzoli M, Cioffi G et al (1996) Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J 132:809\u2013819. https:\/\/doi.org\/10.1016\/S0002-8703(96)90316-6","journal-title":"Am Heart J"},{"key":"10340_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277\u2013314. https:\/\/doi.org\/10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"10340_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00392-018-1221-7","volume":"107","author":"A Palazzuoli","year":"2018","unstructured":"Palazzuoli A, Ruocco G, Beltrami M et al (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clin Res Cardiol 107:586\u2013596. https:\/\/doi.org\/10.1007\/s00392-018-1221-7","journal-title":"Clin Res Cardiol"},{"key":"10340_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2459\/JCM.0000000000000974","volume":"21","author":"NR Pugliese","year":"2020","unstructured":"Pugliese NR, Fabiani I, Conte L et al (2020) Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study. J Cardiovasc Med 21:494\u2013502. https:\/\/doi.org\/10.2459\/JCM.0000000000000974","journal-title":"J Cardiovasc Med"},{"key":"10340_CR20","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1002\/ehf2.13206","volume":"8","author":"L Gargani","year":"2021","unstructured":"Gargani L, Pugliese NR, Frassi F et al (2021) Prognostic value of lung ultrasound in patients hospitalized for heart disease irrespective of symptoms and ejection fraction. ESC Hear Fail 8:2660\u20132669. https:\/\/doi.org\/10.1002\/ehf2.13206","journal-title":"ESC Hear Fail"},{"key":"10340_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1067\/mje.2003.8","volume":"16","author":"FL Dini","year":"2003","unstructured":"Dini FL, Traversi E, Franchini M et al (2003) Contrast-enhanced Doppler hemodynamics for noninvasive assessment of patients with chronic heart failure and left ventricular systolic dysfunction. J Am Soc Echocardiogr 16:124\u2013131. https:\/\/doi.org\/10.1067\/mje.2003.8","journal-title":"J Am Soc Echocardiogr"},{"key":"10340_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jcmg.2017.11.017","volume":"11","author":"E Potter","year":"2018","unstructured":"Potter E, Marwick TH (2018) Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging 11:260\u2013274. https:\/\/doi.org\/10.1016\/j.jcmg.2017.11.017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10340_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/eurjhf\/hft038","volume":"15","author":"E Carluccio","year":"2013","unstructured":"Carluccio E, Dini FL, Biagioli P et al (2013) The \u201cecho heart failure score\u201d: an echocardiographic risk prediction score of mortality in systolic heart failure. Eur J Heart Fail 15:868\u2013876. https:\/\/doi.org\/10.1093\/eurjhf\/hft038","journal-title":"Eur J Heart Fail"},{"key":"10340_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10554-021-02457-z","volume":"38","author":"FL Dini","year":"2022","unstructured":"Dini FL, Ballo P, Pugliese NR et al (2022) Improved diastolic dysfunction is associated with higher forward flow and better prognosis in chronic heart failure. Int J Cardiovasc Imaging 38:727\u2013737. https:\/\/doi.org\/10.1007\/s10554-021-02457-z","journal-title":"Int J Cardiovasc Imaging"},{"key":"10340_CR25","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/ehf2.14037","volume":"9","author":"G Baudry","year":"2022","unstructured":"Baudry G, Coutance G, Dorent R et al (2022) Prognosis value of Forrester\u2019s classification in advanced heart failure patients awaiting heart transplantation. ESC Hear Fail 9:3287\u20133297. https:\/\/doi.org\/10.1002\/ehf2.14037","journal-title":"ESC Hear Fail"},{"key":"10340_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ehjci\/jey172","volume":"20","author":"NR Pugliese","year":"2019","unstructured":"Pugliese NR, Fabiani I, Mandoli GE et al (2019) Echo-derived peak cardiac power output-to-left ventricular mass with cardiopulmonary exercise testing predicts outcome in patients with heart failure and depressed systolic function. Eur Heart J Cardiovasc Imaging 20:700\u2013708. https:\/\/doi.org\/10.1093\/ehjci\/jey172","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10340_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jchf.2016.11.012","volume":"5","author":"St. John Sutton M, Linde C, Gold MR","year":"2017","unstructured":"St. John Sutton M, Linde C, Gold MR, et al (2017) Left ventricular architecture, long-term reverse remodeling, and clinical outcome in mild heart failure with cardiac resynchronization: results from the REVERSE Trial. JACC Hear Fail 5:169\u2013178. https:\/\/doi.org\/10.1016\/j.jchf.2016.11.012","journal-title":"JACC Hear Fail"},{"key":"10340_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.116.003389","volume":"6","author":"T Tobushi","year":"2017","unstructured":"Tobushi T, Nakano M, Hosokawa K et al (2017) Improved diastolic function is associated with higher cardiac output in patients with heart failure irrespective of left ventricular ejection fraction. J Am Heart Assoc 6:1\u20137. https:\/\/doi.org\/10.1161\/JAHA.116.003389","journal-title":"J Am Heart Assoc"},{"key":"10340_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12846","volume":"47","author":"FL Dini","year":"2017","unstructured":"Dini FL, Carluccio E, Montecucco F et al (2017) Combining echo and natriuretic peptides to guide heart failure care in the outpatient setting: a position paper. Eur J Clin Invest 47:e12846","journal-title":"Eur J Clin Invest"},{"key":"10340_CR30","doi-asserted-by":"publisher","unstructured":"N\u00fa\u00f1ez J, de la Espriella R, Rossignol P et al (2022) Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.2664","DOI":"10.1002\/ejhf.2664"},{"key":"10340_CR31","doi-asserted-by":"publisher","unstructured":"von Lueder TG, Kotecha D, Atar D, Hopper I (2017) Neurohormonal blockade in heart failure. Card Fail Rev 03:19. https:\/\/doi.org\/10.15420\/cfr.2016:22:2","DOI":"10.15420\/cfr.2016:22:2"},{"key":"10340_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10741-019-09855-5","volume":"25","author":"NR Pugliese","year":"2020","unstructured":"Pugliese NR, Masi S, Taddei S (2020) The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure. Heart Fail Rev 25:31\u201342","journal-title":"Heart Fail Rev"},{"key":"10340_CR33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ejhf.2848","volume":"25","author":"H Tsutsui","year":"2023","unstructured":"Tsutsui H, Albert NM, Coats AJS et al (2023) Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Eur J Heart Fail 25:616\u2013631","journal-title":"Eur J Heart Fail"},{"key":"10340_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jchf.2021.09.007","volume":"10","author":"PL Myhre","year":"2022","unstructured":"Myhre PL, Prescott MF, Murphy SP et al (2022) Early B-type natriuretic peptide change in HFrEF patients treated with sacubitril\/valsartan: a pooled analysis of EVALUATE-HF and PROVE-HF. JACC Hear Fail 10:119\u2013128. https:\/\/doi.org\/10.1016\/j.jchf.2021.09.007","journal-title":"JACC Hear Fail"},{"key":"10340_CR35","doi-asserted-by":"publisher","unstructured":"Sullivan RD, Mehta RM, Tripathi R,\u00a0Reed GL, Gladysheva IP (2019) Renin activity in heart failure with reduced systolic function-new insights. Int J Mol Sci 20(13):3182. https:\/\/doi.org\/10.3390\/ijms20133182. PMID: 31261774; PMCID: PMC6651297","DOI":"10.3390\/ijms20133182"},{"key":"10340_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/bmjebm-2019-111208","volume":"25","author":"J McLellan","year":"2020","unstructured":"McLellan J, Bankhead CR, Oke JL et al (2020) Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis. BMJ Evidence-Based Med 25:33\u201337","journal-title":"BMJ Evidence-Based Med"},{"key":"10340_CR37","doi-asserted-by":"publisher","unstructured":"Lee KK, Doudesis D, Anwar M et al (2022) Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study. BMJ 377:e068424. https:\/\/doi.org\/10.1136\/bmj-2021-068424","DOI":"10.1136\/bmj-2021-068424"},{"key":"10340_CR38","doi-asserted-by":"publisher","unstructured":"Bettencourt P, Chora I, Silva F et al (2021) Acute on chronic heart failure\u2014which variations on B\u2010type natriuretic peptide levels? J Am Coll Emerg Physicians Open 2. https:\/\/doi.org\/10.1002\/emp2.12448","DOI":"10.1002\/emp2.12448"},{"key":"10340_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1054\/JCAF.2001.26646","volume":"7","author":"AS Maisel","year":"2001","unstructured":"Maisel AS (2001) Practical approaches to treating patients with acute decompensated heart failure. J Card Fail 7:13\u201317. https:\/\/doi.org\/10.1054\/JCAF.2001.26646","journal-title":"J Card Fail"},{"key":"10340_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jchf.2019.12.010","volume":"8","author":"NE Ibrahim","year":"2020","unstructured":"Ibrahim NE, Burnett JC, Butler J et al (2020) Natriuretic peptides as inclusion criteria in clinical trials: a JACC: heart failure position paper. JACC Hear Fail 8:347\u2013358","journal-title":"JACC Hear Fail"},{"key":"10340_CR41","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ejhf.2339","volume":"23","author":"B Moura","year":"2021","unstructured":"Moura B, Aimo A, Al-Mohammad A et al (2021) Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 23:1577\u20131596. https:\/\/doi.org\/10.1002\/ejhf.2339","journal-title":"Eur J Heart Fail"},{"key":"10340_CR42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijcard.2016.09.034","volume":"224","author":"A Simioniuc","year":"2016","unstructured":"Simioniuc A, Carluccio E, Ghio S et al (2016) Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: an observational study of 1137 outpatients. Int J Cardiol 224:416\u2013423. https:\/\/doi.org\/10.1016\/j.ijcard.2016.09.034","journal-title":"Int J Cardiol"},{"key":"10340_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ejhf.705","volume":"19","author":"HN Sabbah","year":"2017","unstructured":"Sabbah HN (2017) Silent disease progression in clinically stable heart failure. Eur J Heart Fail 19:469\u2013478","journal-title":"Eur J Heart Fail"},{"key":"10340_CR44","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ejhf.507","volume":"18","author":"J Butler","year":"2016","unstructured":"Butler J, Gheorghiade M, Metra M (2016) Moving away from symptoms-based heart failure treatment: misperceptions and real risks for patients with heart failure. Eur J Heart Fail 18:350\u2013352","journal-title":"Eur J Heart Fail"},{"key":"10340_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","volume":"4","author":"MA Konstam","year":"2011","unstructured":"Konstam MA, Kramer DG, Patel AR et al (2011) Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 4:98\u2013108","journal-title":"JACC Cardiovasc Imaging"},{"key":"10340_CR46","doi-asserted-by":"publisher","unstructured":"Monosilio S, Filomena D, Luongo F et al (2022) Cardiac and vascular remodeling after 6 months of therapy with sacubitril\/valsartan: mechanistic insights from advanced echocardiographic analysis. Front Cardiovasc Med 9:883769. https:\/\/doi.org\/10.3389\/fcvm.2022.883769","DOI":"10.3389\/fcvm.2022.883769"},{"key":"10340_CR47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jash.2017.05.005","volume":"11","author":"I Fabiani","year":"2017","unstructured":"Fabiani I, Pugliese NR, Conte L et al (2017) Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients. J Am Soc Hypertens 11:412\u2013419. https:\/\/doi.org\/10.1016\/j.jash.2017.05.005","journal-title":"J Am Soc Hypertens"},{"key":"10340_CR48","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","volume":"57","author":"M Merlo","year":"2011","unstructured":"Merlo M, Pyxaras SA, Pinamonti B et al (2011) Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 57:1468\u20131476. https:\/\/doi.org\/10.1016\/j.jacc.2010.11.030","journal-title":"J Am Coll Cardiol"},{"key":"10340_CR49","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","volume":"56","author":"DG Kramer","year":"2010","unstructured":"Kramer DG, Trikalinos TA, Kent DM et al (2010) Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: A meta-analytic approach. J Am Coll Cardiol 56:392\u2013406. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.011","journal-title":"J Am Coll Cardiol"},{"key":"10340_CR50","doi-asserted-by":"publisher","unstructured":"Januzzi JL Jr, Prescott MF, Butler J, Felker GM, Maisel AS, McCague K, Camacho A, Pi\u00f1a IL, Rocha RA, Shah AM, Williamson KM, Solomon SD; PROVE-HF Investigators (2019) Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction. JAMA 322(11):1085\u20131095. https:\/\/doi.org\/10.1001\/jama.2019.12821. PMID: 31475295; PMCID: PMC6724151","DOI":"10.1001\/jama.2019.12821"},{"key":"10340_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jacc.2020.11.008","volume":"77","author":"CG Santos-Gallego","year":"2021","unstructured":"Santos-Gallego CG, Vargas-Delgado AP, Requena-Ibanez JA et al (2021) Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 77:243\u2013255. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.008","journal-title":"J Am Coll Cardiol"},{"key":"10340_CR52","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/EJHF.932","volume":"20","author":"E Gayat","year":"2018","unstructured":"Gayat E, Arrigo M, Littnerova S et al (2018) Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail 20:345\u2013354. https:\/\/doi.org\/10.1002\/EJHF.932","journal-title":"Eur J Heart Fail"},{"key":"10340_CR53","first-page":"504","volume":"7","author":"A Sharma","year":"2022","unstructured":"Sharma A, Verma S, Bhatt DL et al (2022) Optimizing foundational therapies in patients with HFrEF: how do we translate these findings into clinical care? JACC Basic to Transl. Sci 7:504\u2013517","journal-title":"Sci"},{"key":"10340_CR54","doi-asserted-by":"publisher","DOI":"10.2459\/jcm.0000000000001413","author":"V Mercurio","year":"2022","unstructured":"Mercurio V, Ambrosio G, Correale M et al (2022) Innovations in medical therapy of heart failure with reduced ejection fraction. J Cardiovasc Med Publish Ah.\u00a0https:\/\/doi.org\/10.2459\/jcm.0000000000001413","journal-title":"J Cardiovasc Med Publish Ah:"},{"key":"10340_CR55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jchf.2021.06.011","volume":"9","author":"GMC Rosano","year":"2021","unstructured":"Rosano GMC, Allen LA, Abdin A et al (2021) Drug layering in heart failure: phenotype-guided initiation. JACC Hear Fail 9:775\u2013783. https:\/\/doi.org\/10.1016\/j.jchf.2021.06.011","journal-title":"JACC Hear Fail"},{"key":"10340_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2892","author":"F Musella","year":"2023","unstructured":"Musella F, Rosano GMC, Hage C et al (2023) Patient profiles in heart failure with reduced ejection fraction: prevalence, characteristics, treatments and outcomes in a real-world heart failure population. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.2892","journal-title":"Eur J Heart Fail"},{"key":"10340_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2022.01.004","volume":"350","author":"E Carluccio","year":"2022","unstructured":"Carluccio E, Dini FL, Bitto R et al (2022) Benefit from sacubitril\/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: an echocardiographic study. Int J Cardiol 350:62\u201368. https:\/\/doi.org\/10.1016\/j.ijcard.2022.01.004","journal-title":"Int J Cardiol"},{"key":"10340_CR58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ejhf.1351","volume":"21","author":"CN Marti","year":"2019","unstructured":"Marti CN, Fonarow GC, Anker SD et al (2019) Medication dosing for heart failure with reduced ejection fraction \u2014 opportunities and challenges. Eur J Heart Fail 21:286\u2013296","journal-title":"Eur J Heart Fail"},{"key":"10340_CR59","volume-title":"Guyton and hall: textbook of medical physiology","author":"JE Hall","year":"2021","unstructured":"Hall JE, Hall ME (2021) Guyton and hall: textbook of medical physiology, 14th edn. Elsevier","edition":"14"},{"key":"10340_CR60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1056\/nejm199908193410806","volume":"341","author":"RW Schrier","year":"1999","unstructured":"Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577\u2013585. https:\/\/doi.org\/10.1056\/nejm199908193410806","journal-title":"N Engl J Med"},{"key":"10340_CR61","doi-asserted-by":"publisher","unstructured":"Verbrugge FH, Guazzi M, Testani JM, Borlaug BA (2020) Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney. Circulation 142:[in press]. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.045409","DOI":"10.1161\/CIRCULATIONAHA.119.045409"},{"key":"10340_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejim.2021.11.010","volume":"97","author":"C Cogliati","year":"2022","unstructured":"Cogliati C, Ceriani E, Gambassi G et al (2022) Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: the Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study. Eur J Intern Med 97:69\u201377. https:\/\/doi.org\/10.1016\/j.ejim.2021.11.010","journal-title":"Eur J Intern Med"},{"key":"10340_CR63","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ejhf.890","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Mebazaa A, Harjola VP et al (2017) Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19:1242\u20131254. https:\/\/doi.org\/10.1002\/ejhf.890","journal-title":"Eur J Heart Fail"},{"key":"10340_CR64","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1161\/JAHA.119.015009","volume":"9","author":"JJ Park","year":"2020","unstructured":"Park JJ, Mebazaa A, Hwang IC et al (2020) Phenotyping heart failure according to the longitudinal ejection fraction change: myocardial strain, predictors, and outcomes. J Am Heart Assoc 9:15009. https:\/\/doi.org\/10.1161\/JAHA.119.015009","journal-title":"J Am Heart Assoc"},{"key":"10340_CR65","doi-asserted-by":"publisher","first-page":"370","DOI":"10.23736\/S2724-5683.21.05743-4","volume":"70","author":"NR Pugliese","year":"2022","unstructured":"Pugliese NR, de Biase N, Balletti A et al (2022) Characterization of hemodynamic and metabolic abnormalities in the heart failure spectrum: the role of combined cardiopulmonary and exercise echocardiography stress test. Minerva Cardiol Angiol 70:370\u2013384","journal-title":"Minerva Cardiol Angiol"},{"key":"10340_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijcard.2020.11.025","volume":"327","author":"S Ghio","year":"2021","unstructured":"Ghio S, Carluccio E, Scardovi AB et al (2021) Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients. Int J Cardiol 327:111\u2013116. https:\/\/doi.org\/10.1016\/j.ijcard.2020.11.025","journal-title":"Int J Cardiol"},{"key":"10340_CR67","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00392-020-01724-8","volume":"110","author":"M Kobayashi","year":"2021","unstructured":"Kobayashi M, Gargani L, Palazzuoli A et al (2021) Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies. Clin Res Cardiol 110:1181\u20131192. https:\/\/doi.org\/10.1007\/s00392-020-01724-8","journal-title":"Clin Res Cardiol"},{"key":"10340_CR68","doi-asserted-by":"publisher","first-page":"9939","DOI":"10.1161\/CIRCIMAGING.119.009939","volume":"13","author":"D Mele","year":"2020","unstructured":"Mele D, Pestelli G, Dini FL et al (2020) Novel echocardiographic approach to hemodynamic phenotypes predicts outcome of patients hospitalized with heart failure. Circ Cardiovasc Imaging 13:9939. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.009939","journal-title":"Circ Cardiovasc Imaging"},{"key":"10340_CR69","doi-asserted-by":"publisher","unstructured":"Ahmad T, Lund LH, Rao P et al (2018) Machine learning methods improve prognostication, identify clinically distinct phenotypes, and detect heterogeneity in response to therapy in a large cohort of heart failure patients. J Am Heart Assoc 7. https:\/\/doi.org\/10.1161\/JAHA.117.008081","DOI":"10.1161\/JAHA.117.008081"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10340-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:19:52Z","timestamp":1710490792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10340-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["10340"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10340-3","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"7 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}